These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24598803)

  • 1. Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus.
    Mallipattu SK; Gallagher EJ; LeRoith D; Liu R; Mehrotra A; Horne SJ; Chuang PY; Yang VW; He JC
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1008-17. PubMed ID: 24598803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of irisin and FNDC5 rs16835198 G>T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study.
    Khidr EG; Ali SS; Elshafey MM; Fawzy OA
    Gene; 2017 Aug; 626():26-31. PubMed ID: 28479383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice.
    Albrecht T; Schilperoort M; Zhang S; Braun JD; Qiu J; Rodriguez A; Pastene DO; Krämer BK; Köppel H; Baelde H; de Heer E; Anna Altomare A; Regazzoni L; Denisi A; Aldini G; van den Born J; Yard BA; Hauske SJ
    Sci Rep; 2017 Mar; 7():44492. PubMed ID: 28281693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Nakao K
    Clin Exp Nephrol; 2014 Aug; 18(4):584-92. PubMed ID: 24357461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
    Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
    Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.
    Yu L; Su Y; Paueksakon P; Cheng H; Chen X; Wang H; Harris RC; Zent R; Pozzi A
    Kidney Int; 2012 Jun; 81(11):1086-97. PubMed ID: 22297672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.
    Østergaard MV; Pinto V; Stevenson K; Worm J; Fink LN; Coward RJ
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F312-F321. PubMed ID: 27852608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular expression pattern of long non-coding RNAs in the type 2 diabetes mellitus BTBR mouse model.
    Reichelt-Wurm S; Wirtz T; Chittka D; Lindenmeyer M; Reichelt RM; Beck S; Politis P; Charonis A; Kretz M; Huber TB; Liu S; Banas B; Banas MC
    Sci Rep; 2019 Jul; 9(1):9765. PubMed ID: 31278342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.
    Novosyadlyy R; Lann DE; Vijayakumar A; Rowzee A; Lazzarino DA; Fierz Y; Carboni JM; Gottardis MM; Pennisi PA; Molinolo AA; Kurshan N; Mejia W; Santopietro S; Yakar S; Wood TL; LeRoith D
    Cancer Res; 2010 Jan; 70(2):741-51. PubMed ID: 20068149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
    Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
    Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a diabetic mouse model with progressive diabetic nephropathy.
    Inada A; Nagai K; Arai H; Miyazaki J; Nomura K; Kanamori H; Toyokuni S; Yamada Y; Bonner-Weir S; Weir GC; Fukatsu A; Seino Y
    Am J Pathol; 2005 Aug; 167(2):327-36. PubMed ID: 16049320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury.
    Vijayakumar A; Buffin NJ; Gallagher EJ; Blank J; Wu Y; Yakar S; LeRoith D
    Endocrinology; 2013 Oct; 154(10):3776-83. PubMed ID: 23861377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
    Deb DK; Sun T; Wong KE; Zhang Z; Ning G; Zhang Y; Kong J; Shi H; Chang A; Li YC
    Kidney Int; 2010 Jun; 77(11):1000-9. PubMed ID: 20182412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FABP1 and FABP2 as markers of diabetic nephropathy.
    Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
    Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
    Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
    Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus.
    Choi GS; Min HS; Cha JJ; Lee JE; Ghee JY; Yoo JA; Kim KT; Kang YS; Han SY; Bae YS; Lee SR; Yoo JY; Moon SH; Lee SJ; Cha DR
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):498-505. PubMed ID: 33223406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.
    Friedman AN; Chambers M; Kamendulis LM; Temmerman J
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1892-8. PubMed ID: 23929927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of variants rs5030717 and rs5030718 of TLR4 in the risk prediction of nephropathy, hypertension and dyslipidaemia in type 2 diabetes mellitus.
    Abbas SA; Raza ST; Mir SS; Siddiqi Z; Zaidi A; Zaidi ZH; Mahdi F
    Br J Biomed Sci; 2018 Oct; 75(4):163-168. PubMed ID: 30211669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.